Diagnostic ultrasound ( PDFDrive )

CHAPTER 15 The Uterus 561
107. Lev-Toaf AS, Toaf ME, Liu JB, et al. Value of sonohysterography in the
diagnosis and management of abnormal uterine bleeding. Radiology.
1996;201(1):179-184.
108. Parsons AK, Lense JJ. Sonohysterography for endometrial abnormalities:
preliminary results. J Clin Ultrasound. 1993;21(2):87-95.
109. Dubinsky TJ, Parvey HR, Gormaz G, Makland N. Transvaginal hysterosonography
in the evaluation of small endoluminal masses. J Ultrasound
Med. 1995;14(1):1-6.
110. Jorizzo JR, Riccio GJ, Chen MY, Carr JJ. Sonohysterography: the next step
in the evaluation of the abnormal endometrium. Radiographics. 1999;Spec
No. 19:S117-S130.
111. Dubinsky TJ, Stroehlein K, Abu-Ghazzeh Y, et al. Prediction of benign and
malignant endometrial disease: hysterosonographic-pathologic correlation.
Radiology. 1999;210(2):393-397.
112. Laifer-Narin SL, Ragavendra N, Lu DS, et al. Transvaginal saline hysterosonography:
characteristics distinguishing malignant and various benign
conditions. AJR Am J Roentgenol. 1999;172(6):1513-1520.
113. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and beneits of estrogen
plus progestin in healthy postmenopausal women: principal results from
the Women’s Health Initiative randomized controlled trial. JAMA.
2002;288(3):321-333.
114. Levine D, Gosink BB, Johnson LA. Change in endometrial thickness in
postmenopausal women undergoing hormone replacement therapy. Radiology.
1995;197(3):603-608.
115. Malfetano JH. Tamoxifen-associated endometrial carcinoma in postmenopausal
breast cancer patients. Gynecol Oncol. 1990;39(1):82-84.
116. Kedar RP, Bourne TH, Powles TJ, et al. Efects of tamoxifen on uterus and
ovaries of postmenopausal women in a randomised breast cancer prevention
trial. Lancet. 1994;343(8909):1318-1321.
117. Lahti E, Blanco G, Kauppila A, et al. Endometrial changes in postmenopausal
breast cancer patients receiving tamoxifen. Obstet Gynecol. 1993;81(5 Pt
1):660-664.
118. Hann LE, Giess CS, Bach AM, et al. Endometrial thickness in tamoxifentreated
patients: correlation with clinical and pathologic indings. AJR Am
J Roentgenol. 1997;168(3):657-661.
119. Cohen I, Rosen DJ, Tepper R, et al. Ultrasonographic evaluation of the
endometrium and correlation with endometrial sampling in postmenopausal
patients treated with tamoxifen. J Ultrasound Med. 1993;12(5):275-280.
120. Hulka CA, Hall DA. Endometrial abnormalities associated with tamoxifen
therapy for breast cancer: sonographic and pathologic correlation. AJR Am
J Roentgenol. 1993;160(4):809-812.
121. Ascher SM, Imaoka I, Lage JM. Tamoxifen-induced uterine abnormalities:
the role of imaging. Radiology. 2000;214(1):29-38.
122. Cohen I, Bernheim J, Azaria R, et al. Malignant endometrial polyps in
postmenopausal breast cancer tamoxifen-treated patients. Gynecol Oncol.
1999;75(1):136-141.
123. Goldstein SR. Unusual ultrasonographic appearance of the uterus in patients
receiving tamoxifen. Am J Obstet Gynecol. 1994;170(2):447-451.
124. Fong K, Kung R, Lytwyn A, et al. Endometrial evaluation with transvaginal
US and hysterosonography in asymptomatic postmenopausal women
with breast cancer receiving tamoxifen. Radiology. 2001;220(3):765-
773.
125. Wong AW, Lao TH, Cheung CW, et al. Reappraisal of endometrial thickness
for the detection of endometrial cancer in postmenopausal bleeding: a
retrospective cohort study. BJOG. 2016;123(3):439-446.
126. Varner RE, Sparks JM, Cameron CD, et al. Transvaginal sonography of the
endometrium in postmenopausal women. Obstet Gynecol. 1991;78(2):
195-199.
127. Karlsson B, Granberg S, Wikland M, et al. Transvaginal ultrasonography
of the endometrium in women with postmenopausal bleeding—a Nordic
multicenter study. Am J Obstet Gynecol. 1995;172(5):1488-1494.
128. Ferrazzi E, Torri V, Trio D, et al. Sonographic endometrial thickness: a
useful test to predict atrophy in patients with postmenopausal bleeding.
An Italian multicenter study. Ultrasound Obstet Gynecol. 1996;7(5):
315-321.
129. Granberg S, Wikland M, Karlsson B, et al. Endometrial thickness as measured
by endovaginal ultrasonography for identifying endometrial abnormality.
Am J Obstet Gynecol. 1991;164(1 Pt 1):47-52.
130. Nasri MN, Shepherd JH, Setchell ME, et al. he role of vaginal scan in
measurement of endometrial thickness in postmenopausal women. Br J
Obstet Gynaecol. 1991;98(5):470-475.
131. Goldstein SR, Nachtigall M, Snyder JR, Nachtigall L. Endometrial assessment
by vaginal ultrasonography before endometrial sampling in patients with
postmenopausal bleeding. Am J Obstet Gynecol. 1990;163(1 Pt 1):
119-123.
132. Choo YC, Mak KC, Hsu C, et al. Postmenopausal uterine bleeding of
nonorganic cause. Obstet Gynecol. 1985;66(2):225-228.
133. Atri M, Nazarnia S, Aldis AE, et al. Transvaginal US appearance of endometrial
abnormalities. Radiographics. 1994;14(3):483-492.
134. Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. Endovaginal ultrasound
to exclude endometrial cancer and other endometrial abnormalities. JAMA.
1998;280(17):1510-1517.
135. Breijer M, Molb B. Transvaginal ultrasound measurement of the endometrium
remains the irst line test for investigating postmenopausal bleeding but
integration of patient characteristics into testing may further improve
diagnostic algorithms. BJOG. 2016;123(3):447.
136. Delisle MF, Villeneuve M, Boulvain M. Measurement of endometrial thickness
with transvaginal ultrasonography: is it reproducible? J Ultrasound Med.
1998;17(8):481-484.
137. Goldstein RB, Bree RL, Benson CB, et al. Evaluation of the woman with
postmenopausal bleeding: Society of Radiologists in Ultrasound–Sponsored
Consensus Conference statement. J Ultrasound Med. 2001;20(10):1025-
1036.
138. Bree RL, Bowerman RA, Bohm-Velez M, et al. US evaluation of the uterus
in patients with postmenopausal bleeding: a positive efect on diagnostic
decision making. Radiology. 2000;216(1):260-264.
139. Laifer-Narin S, Ragavendra N, Parmenter EK, Grant EG. False-normal
appearance of the endometrium on conventional transvaginal sonography:
comparison with saline hysterosonography. AJR Am J Roentgenol.
2002;178(1):129-133.
140. Dubinsky TJ, Parvey HR, Gormaz G, et al. Transvaginal hysterosonography:
comparison with biopsy in the evaluation of postmenopausal bleeding.
J Ultrasound Med. 1995;14(12):887-893.
141. Jokubkiene L, Sladkevicius P, Valentin L. Transvaginal ultrasound examination
of the endometrium in postmenopausal women without vaginal bleeding.
Ultrasound Obstet Gynecol. 2016;48(3):390-396.
142. Wilson DA, Stacy TM, Smith EI. Ultrasound diagnosis of hydrocolpos and
hydrometrocolpos. Radiology. 1978;128(2):451-454.
143. Breckenridge JW, Kurtz AB, Ritchie WG, Macht Jr EL. Postmenopausal
uterine luid collection: indicator of carcinoma. AJR Am J Roentgenol.
1982;139(3):529-534.
144. Scott Jr WW, Rosenshein NB, Siegelman SS, Sanders RC. he obstructed
uterus. Radiology. 1981;141(3):767-770.
145. Pretorius DH, Dennis MA, Manco-Johnson ML, Gottesfeld KR. Ultrasound
diagnosis of hematotrachelos: a case report. Am J Obstet Gynecol.
1985;151(8):1080-1082.
146. Lewit N, haler I, Rottem S. he uterus: a new look with transvaginal
sonography. J Clin Ultrasound. 1990;18(4):331-336.
147. McCarthy KA, Hall DA, Kopans DB, Swann CA. Postmenopausal endometrial
luid collections: always an indicator of malignancy? J Ultrasound Med.
1986;5(11):647-649.
148. Vuento MH, Pirhonen JP, Makinen JI, et al. Endometrial luid accumulation
in asymptomatic postmenopausal women. Ultrasound Obstet Gynecol.
1996;8(1):37-41.
149. Kurman RJ, editor. Blaustein’s pathology of the female genital tract. 5th ed.
New York: Springer-Verlag; 2002.
150. Sheth S, Hamper UM, Kurman RJ. hickened endometrium in the postmenopausal
woman: sonographic-pathologic correlation. Radiology.
1993;187(1):135-139.
151. Hulka CA, Hall DA, McCarthy K, Simeone JF. Endometrial polyps,
hyperplasia, and carcinoma in postmenopausal women: diferentiation
with endovaginal sonography. Radiology. 1994;191(3):755-
758.
152. Kupfer MC, Schiller VL, Hansen GC, Tessler FN. Transvaginal sonographic
evaluation of endometrial polyps. J Ultrasound Med. 1994;13(7):
535-539.